Namaste Announces Record Breaking Quarterly Sales of $4.9M Representing a 133% Year-on-Year Increase

FOR IMMEDIATE RELEASE – January 29th, 2018

NAMASTE ANNOUNCES RECORD-BREAKING QUARTERLY SALES OF $4.9M REPRESENTING A 133% YEAR-ON-YEAR INCREASE

Vancouver, British Columbia, Canada – Namaste Technologies Inc. (“Namaste” or the “Company”) (CSE:N), (FRANKFURT: M5BQ), (OTCMKTS: NXTTF) is pleased to announce the filing of its unaudited quarterly financial statements, management’s discussion and analysis and certification of the quarterly filings for the first quarter of fiscal 2017. The statements for the period can be accessed on SEDAR at www.sedar.com. The Company’s sales for the three months ending on November 30, 2017, were $4.9M, representing a $2.8M or 136% increase in comparison with the Company’s quarter ended November 30, 2016.   Gross margin also increased to 32% for the three months ended on November 30, 2017, in comparison to 28% for the Company’s quarter ended November 30, 2016.

During the financial reporting period of September 1, 2017, to November 30, 2017, the Company focused on expanding sales in existing territories as well as in emerging markets such as Mexico and Brazil while reducing sales exposure in the United States.

The Company also sold its US assets and operations as a strategic decision to eliminate risk related to US market exposure.

The Company remains focused on achieving profitability and on launching its medical cannabis marketplace, NamasteMD, through our wholly-owned subsidiary, Cannmart Inc.

Quarterly Financial Highlights

Revenues by country
Country November 30, 2017 November 30, 2016
Great Britain   1,233,983   547,281
Australia   1,516,582   –
United States of America   677,552   912,011
Brazil   354,444   101,923
Canada   355,632   80,238
New Zealand   104,484   134,168
Germany   262,610   23,437
Ireland   61,820   35,505
Israel   62,844   22,236
Other   301,160   230,389
Total   $4,931,110   $2,087,188

Management Commentary

Sean Dollinger, President and CEO of Namaste comments: “During the first quarter ended November 30, 2017, Namaste embarked on implementing many strategic business initiatives focused on expansion in international markets other than the United States. In addition, posting record-breaking revenues, management remains focused on seeking and securing strong partnerships to further accelerate growth going forward. We expect to see significant upside to Namaste’s revenue and profitability as a direct result of the many acquisitions and partnerships that were initiated both during and following this quarter. Management believes there are many more strategic opportunities that exist in the cannabis market that will serve to strengthen Namaste’s position moving forward. In particular, the NamasteMD platform will be a key driver of growth.  We are extremely excited at where the industry is headed and believe Namaste is well-positioned in 2018 and beyond.”

About Namaste Technologies Inc.

Namaste is the largest online retailer of medical cannabis delivery systems globally. Namaste distributes vaporizers and smoking accessories through e-commerce sites in 26 countries and with 5 distribution hubs located around the world. Namaste has majority market share in Europe and Australia, with operations in the UK, Canada, and Germany and has opened new supply channels into emerging markets including Brazil, Mexico and Chile. Namaste, through its acquisition of Cannmart Inc., a Canadian based late-stage applicant for a medical cannabis distribution license (under the ACMPR Program) is pursuing a new revenue vertical in online retail of medical cannabis in the Canadian market. Namaste intends to leverage its existing database of Canadian medical cannabis consumers, along with its expertise in e-commerce to create an online marketplace for medical cannabis patients, offering a larger variety of product and a better user experience.

Forward-Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law.

Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents which can be found under the Company’s profile on www.sedar.com.

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The CSE has neither reviewed nor approved the contents of this press release

On behalf of the Board of Directors

“Sean Dollinger”

Chief Executive Officer

Direct: +1 (786) 389 9771

Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

newcorpsite.namastetechnologies.com

www.namastevaporizers.co.uk

www.everyonedoesit.co.uk

www.australianvaporizers.com